Despite the pressures that Pfizer has faced and will face on the top line, the company will be able to deliver on their earnings target, in part aided by introduction of their new drugs.
The only way this company can improve their earnings is through pursuing a merger or by being acquired. It's not very innovative, but it's what they're going to have to do.
Bristol-Myers earnings will be down this year but then we expect to see a recovery based on the introduction of new drugs and cost cuts.
They made the consensus numbers even after taking that charge. The stock has already been pummeled in the last few years. I think with all things taken into account, the earnings were a little better than expected.
They made the consensus numbers even after taking that charge, ... The stock has already been pummeled in the last few years. I think with all things taken into account, the earnings were a little better than expected.